Omeprazole Noridem (Omeprazole Sodium)

Omeprazole Noridem is a proton pump inhibitor used to manage conditions linked to excess gastric acid production.

• Peptic ulcer disease: promotes healing of gastric and duodenal ulcers.
• Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and esophageal irritation.
• Stress‑related mucosal damage: helps prevent ulceration in critically ill patients.
• Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Omeprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By irreversibly binding to this pump, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Common Side Effects

• Headache
• Diarrhea
• Nausea
• Abdominal pain
• Flatulence
• Dizziness

Serious or Rare Side Effects

• Clostridioides difficile‑associated colitis
• Acute interstitial nephritis
• Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome)
• Hepatotoxicity
• Hypomagnesemia
• Bone fractures with long‑term use

Omeprazole Noridem should be used only under medical supervision, particularly in patients with liver impairment or those receiving multiple medications.

• Liver function monitoring: assess hepatic enzymes before and during therapy.
• Renal function monitoring: evaluate kidney function in patients with existing renal disease.
• Drug‑interaction review: check for concomitant use of drugs that require gastric acidity for absorption.
• Pregnancy and lactation: use only if clearly indicated.
• Long‑term therapy assessment: re‑evaluate need for continued use after several months.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Omeprazole Noridem may affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole, itraconazole: reduced antifungal absorption.
• Atazanavir, nelfinavir: markedly decreased antiviral efficacy.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR.
• Digoxin: possible rise in serum levels.
• Methotrexate: reduced renal clearance may increase toxicity.
• Phenytoin: altered metabolism may affect seizure control.